Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis.
Schouten N, Wang R, Torrance H, Van Tilborg T, Bastu E, Bergh C, D'Hooghe T, Friis Petersen J, Jayaprakasan K, Khalaf Y, Klinkert E, La Marca A, Vuong L, Lapensée L, Lensen S, Magnusson Å, Allegra A, Nyboe Andersen A, Oudshoorn S, Popovic-Todorovic B, Mol BW, Eijkemans M, Broekmans F. Schouten N, et al. Among authors: d hooghe t. Hum Reprod Update. 2024 Dec 20:dmae032. doi: 10.1093/humupd/dmae032. Online ahead of print. Hum Reprod Update. 2024. PMID: 39707165
A Cost-Effectiveness Analysis of Gonadotropins Used for Ovarian Stimulation during Assisted Reproductive Technology Based on Data from the French Nationwide Claims Database (SNDS).
Borget I, Benchaib M, Poignant P, Rey L, Harty G, Chaudhari V, D'hooghe T, Schwarze JE, Cedrin Durnerin I, Roeder C, Grynberg M. Borget I, et al. Among authors: d hooghe t. Gynecol Obstet Invest. 2024 Nov 19:1-15. doi: 10.1159/000542074. Online ahead of print. Gynecol Obstet Invest. 2024. PMID: 39561733 Free article.
Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria.
Alviggi C, Humaidan P, Fischer R, Conforti A, Dahan MH, Marca A, Orvieto R, Polyzos NP, Roque M, Sunkara SK, Ubaldi FM, Vuong L, Yarali H, D'Hooghe T, Longobardi S, Esteves SC. Alviggi C, et al. Among authors: d hooghe t. Reprod Biol Endocrinol. 2024 Oct 10;22(1):122. doi: 10.1186/s12958-024-01291-x. Reprod Biol Endocrinol. 2024. PMID: 39385174 Free PMC article.
426 results